A recent clinical study has highlighted the potential of a traditional Chinese herbal remedy, Fufang Xuanju capsule, in treating sexual dysfunction linked to late-onset hypogonadism (LOH). This condition, affecting middle-aged and older men, is characterised by declining testosterone levels and symptoms such as reduced libido and erectile dysfunction. The findings provide hope for men seeking non-hormonal treatment options, particularly those unable to undergo testosterone replacement therapy (TRT) due to health risks. The findings were published in the journal Medicine.
The research, conducted over three months, enrolled 111 men diagnosed with LOH. Participants were split into two groups, with 57 receiving Fufang Xuanju capsules and 50 placed in a placebo group. The herbal capsules, derived from four Chinese medicinal herbs, are designed to enhance kidney function and strengthen Yang, an approach rooted in traditional Chinese medical practices.
The study revealed that men in the treatment group experienced significant improvements in sexual health compared to those taking a placebo. Their scores on the International Index of Erectile Function-5 (IIEF-5), a standard measure for erectile dysfunction, increased from an average of 11.2 to 17.9. Patients also reported heightened libido and overall satisfaction. These benefits were particularly pronounced in individuals with mild to moderate erectile dysfunction.
Unlike TRT, which raises testosterone levels, the Fufang Xuanju capsule demonstrated its effectiveness without altering hormone levels. This non-hormonal mechanism of action makes it a safer option for men with conditions that preclude hormone therapy, such as prostate or cardiovascular concerns.
The study also emphasised the treatment’s safety profile. Participants reported no severe adverse effects, with only a few experiencing mild side effects like nausea. Additionally, key health parameters, including prostate size, blood lipids, and glucose levels, remained stable throughout the trial.
The herbal components of the Fufang Xuanju capsule, including Epimedium brevicornum and Lycium barbarum, have a long history of use in traditional Chinese medicine. These ingredients are believed to enhance reproductive health and vitality. Previous studies in animals have shown that these herbs improve erectile function and bolster general well-being, aligning with the clinical outcomes observed in this trial.
Despite the promising results, researchers cautioned that this study was limited by its relatively small sample size and short duration. They called for larger-scale, multicentre trials to validate the findings and investigate long-term efficacy and safety. If confirmed, Fufang Xuanju capsule could emerge as a valuable alternative to TRT, offering relief for men with LOH while avoiding the risks associated with hormonal therapies.
This development marks an encouraging step forward in addressing the challenges of male sexual dysfunction. By bridging traditional and modern medical approaches, treatments like Fufang Xuanju capsule may provide effective and safer solutions for improving the quality of life in ageing men.
